NDC 70518-1365

Atazanavir Sulfate

Atazanavir

Atazanavir Sulfate is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Remedyrepack Inc.. The primary component is Atazanavir Sulfate.

Product ID70518-1365_731b7a35-b412-a3d6-e053-2991aa0a20b2
NDC70518-1365
Product TypeHuman Prescription Drug
Proprietary NameAtazanavir Sulfate
Generic NameAtazanavir
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2018-08-09
Marketing CategoryANDA / ANDA
Application NumberANDA204806
Labeler NameREMEDYREPACK INC.
Substance NameATAZANAVIR SULFATE
Active Ingredient Strength300 mg/1
Pharm ClassesHIV Protease Inhibitors [MoA],Protease Inhibitor [EPC],UGT1A1 Inhibitors [MoA],UDP Glucuronosyltransferases Inhibitors [MoA],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA],Cytochrome P450 2C8 Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 70518-1365-0

30 CAPSULE in 1 BLISTER PACK (70518-1365-0)
Marketing Start Date2018-08-09
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 70518-1365-0 [70518136500]

Atazanavir Sulfate CAPSULE
Marketing CategoryANDA
Application NumberANDA204806
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-08-09

Drug Details

Active Ingredients

IngredientStrength
ATAZANAVIR SULFATE300 mg/1

OpenFDA Data

SPL SET ID:c315d2a7-4163-45ba-92cb-86fd6a8c8093
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 664741
  • Pharmacological Class

    • HIV Protease Inhibitors [MoA]
    • Protease Inhibitor [EPC]
    • UGT1A1 Inhibitors [MoA]
    • UDP Glucuronosyltransferases Inhibitors [MoA]
    • Cytochrome P450 3A4 Inhibitors [MoA]
    • Cytochrome P450 3A Inhibitors [MoA]
    • Cytochrome P450 2C8 Inhibitors [MoA]

    NDC Crossover Matching brand name "Atazanavir Sulfate" or generic name "Atazanavir"

    NDCBrand NameGeneric Name
    0093-5526Atazanavir SulfateAtazanavir Sulfate
    0093-5527Atazanavir SulfateAtazanavir Sulfate
    0093-5528Atazanavir SulfateAtazanavir Sulfate
    0904-6875Atazanavir SulfateAtazanavir
    16714-860Atazanavir SulfateAtazanavir
    16714-861Atazanavir SulfateAtazanavir
    16714-862Atazanavir SulfateAtazanavir
    70518-1365Atazanavir SulfateAtazanavir Sulfate
    70518-0946Atazanavir SulfateAtazanavir Sulfate
    51407-172Atazanavir SulfateAtazanavir Sulfate
    51407-171Atazanavir SulfateAtazanavir Sulfate
    51407-173Atazanavir SulfateAtazanavir Sulfate
    60687-399Atazanavir SulfateAtazanavir Sulfate
    65862-712Atazanavir SulfateAtazanavir Sulfate
    65862-713Atazanavir SulfateAtazanavir Sulfate
    65862-710Atazanavir SulfateAtazanavir Sulfate
    65862-711Atazanavir SulfateAtazanavir Sulfate
    31722-653AtazanavirAtazanavir
    31722-654AtazanavirAtazanavir
    31722-655AtazanavirAtazanavir
    42385-920AtazanavirAtazanavir
    0003-3622REYATAZATAZANAVIR
    0003-3624REYATAZATAZANAVIR
    0003-3631REYATAZATAZANAVIR
    0003-3638REYATAZATAZANAVIR

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.